𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Predicting Morbidity and Mortality After Hepatic Resection in Patients with Hepatocellular Carcinoma: The Role of Model for End-Stage Liver Disease Score

✍ Scribed by Kuang-Yu Hsu; Gar-Yang Chau; Wing-Yiu Lui; Shyh-Haw Tsay; Kuang-Liang King; Chew-Wun Wu

Publisher
Springer
Year
2009
Tongue
English
Weight
241 KB
Volume
33
Category
Article
ISSN
0364-2313

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Determination of the optimal model for e
Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy
✍ Teh-Ia Huo; Jaw-Ching Wu; Han-Chieh Lin; Fa-Yauh Lee; Ming-Chih Hou; Yi-Hsiang H πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 100 KB πŸ‘ 1 views

The model for end-stage liver disease (MELD) has been a prevailing system to prioritize cirrhotic patients awaiting liver transplantation. An "exceptional" MELD score of 20 and 24 points is assigned for stage T1 and T2 patients with small hepatocellular carcinoma (HCC), respectively. However, this s

Survival after liver transplantation for
Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre–model for end-stage liver disease eras and the independent impact of hepatitis C virus
✍ Paul J. Thuluvath; Anurag Maheshwari; Nimisha P. Thuluvath; Geoffrey C. Nguyen; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 248 KB πŸ‘ 1 views

It has been suggested that hepatitis C virus (HCV) patients with hepatocellular carcinoma (HCC) may have worse outcomes after liver transplantation (LT) because of more aggressive tumor biology. In this study, we determined the post-LT survival of HCC patients with and without HCV using United Netwo

The model for end-stage liver disease-ba
The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy
✍ Teh-Ia Huo; Han-Chieh Lin; Yi-Hsiang Huang; Jaw-Ching Wu; Jen-Huei Chiang; Pui-C πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 190 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The Japan Integrated Scoring (JIS) system was revealed as a better model for outcome prediction compared with the Cancer of Liver Italian Program system for hepatocellular carcinoma (HCC), and the Model for End‐Stage Liver Disease (MELD) was better as a prognostic predict

Frequency and predictors of de novo hepa
Frequency and predictors of de novo hepatocellular carcinoma in patients awaiting orthotopic liver transplantation during the model for end-stage liver disease era
✍ Carla W. Brady; Alastair D. Smith; Karen M. Stechuchak; Cynthia J. Coffman; Jane πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 104 KB πŸ‘ 1 views

In the current system of allocation, patients awaiting orthotopic liver transplantation (OLT) remain at risk of developing de novo hepatocellular carcinoma (HCC) and removal from the waiting list. Using the United Network for Organ Sharing database, we calculated the rate and identified predictors o

Proposal of a modified Child-Turcotte-Pu
Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis
✍ Teh-Ia Huo; Han-Chieh Lin; Jaw-Ching Wu; Fa-Yauh Lee; Ming-Chih Hou; Pui-Ching L πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 224 KB πŸ‘ 1 views

The model for end-stage liver disease (MELD) has a better predictive accuracy for survival than the Child-Turcotte-Pugh (CTP) system and has been the primary reference for organ allocation in liver transplantation. The CTP system, with a score range of 5-15, has a ceiling effect that may compromise